Lary ngeal plasmacytoma is rare in Japan; to the best of ou r knowledge, only 8 other cases have been previously reported. We report a new case of extramedullary plasmacytoma of the larynx in a 76-year-old Japan ese woman. Immunohistochemical investigation reveal ed that her disease had not progressed to multiple myeloma . The patient declined radiot herapy, and her condition remained stab le at the ti-month fo llow-up.
Introduction
Extramedullary plasmacytoma accounts for only 0.2% of all tumors of the head and neck. I In Japan, only 8 cases of extramedullary plasmacytoma of the larynx have been previously reported."? In this article, we describe a new case of extramedullary plasmacytoma of the larynx.
Case repo rt
A 76-year-old Japanese woman underwent endo scopy during an eva luation of reflux esophagitis at another hospital. During this examination , a tumor in the supraglottic area was detected (figure I). The patie nt was referred to our hospital.
At the referral encou nter, the patient denied any laryngopharyngeal symptoms. Abiopsy ofthe tumor was performed with the patient under general ane sthesia. Histopathologic examination revea led that the mass was an extramedullary plasmacytoma of the larynx. Hematoxylin and eosin (H&E) staining showed atypica l plasma cells that had large, irregular nuclei on concentrated staining (figure 2). Immunohistochemically, these atypical cells reacted positive ly for the epithelial membrane antigen (EMA), CD38, and the kappa light chain. However, M protein, Bence Jones protein, and an abnormal accumulation of ga llium were not detected. Moreover, no abno rmal cells were observed on bone marrow biopsy. Based on these findings, we were able to rule out progression to multiple myeloma. The patient prefe rred not to undergo any radica l treatment. At the 6-month follow-up, we did not observe any enlargement of the tumor or progression to multiple myeloma. The patie nt was subsequently lost to follow-up.
Discussion
Willis classified plasmacy toma s as either medullary or extramedullary and either solitary or multiple.10 The multiple med ullary type is called multiple myeloma. The term extramedullary plasmacytoma doe s not apply to tumors that have arisen in bone marrow and broken thro ugh the cor tex to form an assoc iated soft-tiss ue mass.
Overall, approximately 70 to 80 % of extramedullary plasmacytomas involve the head and neck-about two-third s in the nose, sinuses, and nasopharynx. ':" As mentioned, extr amedullary plasmacytoma of the larynx is rare in Japan ; to the best of our knowledge, ours is only the ninth reported case .
Diagnosis. Immunologic studies are useful for detecting evidence of extramedullary plasmacytoma .12 In our case, the tumor specimen showed positive reactions for EMA, CD38, and the kappa light chain. No M protein , Bence Jones prote in, accumulation of gallium, or abnormal cells in bone marrow were detected, which suggested that the plasmacytoma had not developed into multiple myeloma.
Treatment. For extramedullary plasmacytomas of the larynx, some authorities recommend radiotherapy as the first line of'treatment.Y'>" However, in Japan, radiotherapy has not been effective in all cases. In the 8 previously reported cases,S patie nts underwent radiotherapy ; it was successful in 3 patientsv-? and ineffec tive in 2 patients ." As a resu lt of the paucity of cases and a lack of long-term follow -up data for the cases that have been documented, a definitive first-line treatment has not been established in Japan. Our patient declined radiotherapy, and her tumor status remained stable at the 6-month follow -up. She was subsequently lost to follow -up .
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